Electrosclerotherapy for low-flow venous malformations
Treatments studied
Part of Genetic & congenital, Heart & circulation clinical trials.
This study is testing a treatment called electrosclerotherapy for low-flow venous malformations. It uses a medicine (bleomycin) injected into the abnormal blood vessels to shrink them. The goal is to see how well it works and how safe it is.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with low-flow venous malformations (a type of slow-moving abnormal blood vessel).
- You have not had any treatment for this condition in the last 30 days.
- You are not pregnant or breastfeeding, and if you are of childbearing age, you use reliable contraception.
- You have not had a bad reaction to bleomycin, and you have not already received a high dose of bleomycin (100 mg or more) in the past.
- You do not have severe lung disease, poor kidney function, metal implants in the area, a history of seizures or epilepsy, or previous chest radiation therapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a treatment called bleomycin electrosclerotherapy (BEST) for people with low-flow vascular malformations—abnormal clusters of blood or lymph vessels that can cause pain or swelling. The treatment combines a drug (bleomycin) with a small electrical current to shrink these abnormal vessels, and the goal is to see if it helps when other treatments haven't worked well or the problem came back.
This trial tests a treatment called bleomycin electrosclerotherapy for people with slow-flow vascular malformations (abnormal blood vessels that do not flow quickly). The goal is to see if this treatment works well and is safe for these conditions.
This study tests a treatment that uses microwave energy to shrink painful or troublesome abnormal blood vessels (vascular malformations). It may help reduce symptoms like pain and swelling without open surgery.
This trial tests a treatment called electrochemotherapy for tumors in internal organs (like the liver or pancreas) when standard treatments are no longer possible. It uses a drug called bleomycin plus electric pulses to target cancer cells.
This Phase 2 study compares adding electrotherapy to give carboplatin plus bleomycin directly to the tumor versus giving bleomycin alone. It may help shrink recurrent vulvar cancer when standard options aren’t suitable and your health is limited.
This trial tests a medicine called bleomycin, injected into lymphatic malformations (abnormal fluid-filled growths) to shrink them. It is for children under 14 whose malformations are growing quickly, causing symptoms or problems, and cannot be removed by surgery alone.
Hear when a new Vascular Malformations trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.